110 related articles for article (PubMed ID: 8458676)
1. Iron protein succinylate: preclinical safety assessment.
Forster R
Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):53-60. PubMed ID: 8458676
[TBL] [Abstract][Full Text] [Related]
2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
3. Comparison of anti-anaemic effects of iron protein succinylate (ITF 282) and ferrous sulfate in the rat.
Caramazza I; Andriuoli G; Scagnol I; Del Soldato P
Drugs Exp Clin Res; 1990; 16(7):333-42. PubMed ID: 2092959
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children.
Haliotis FA; Papanastasiou DA
Int J Clin Pharmacol Ther; 1998 Jun; 36(6):320-5. PubMed ID: 9660039
[TBL] [Abstract][Full Text] [Related]
5. [Legofer--a new approach in the treatment of iron deficiency. Pharmacological and biopharmacological characteristics of legofer (ferric protein succinylate)].
Akush Ginekol (Sofiia); 2002; 41 Suppl 1():21-3. PubMed ID: 12412350
[No Abstract] [Full Text] [Related]
6. Efficacy and tolerability of oral iron protein succinylate: a systematic review of three decades of research.
Martínez Francés A; Leal Martínez-Bujanda J
Curr Med Res Opin; 2020 Apr; 36(4):613-623. PubMed ID: 31944128
[No Abstract] [Full Text] [Related]
7. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
8. [Iron protein-succinylate in the treatment of adult iron-deficiency anemia].
Pujol Farriols R; Anglada Oriol M; Formiga Pérez F; Fernández-Sabe N; Mitjavila Vileró F; Vidaller Palacín A
An Med Interna; 2002 Dec; 19(12):651-2. PubMed ID: 12593038
[No Abstract] [Full Text] [Related]
9. Iron protein succynilate in the treatment of iron deficiency: potential interaction with H2-receptor antagonists.
Bianchi FM; Cavassini GB; Leo P
Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):209-17. PubMed ID: 8100220
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
11. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1992 Mar; 407():1-289. PubMed ID: 12621523
[TBL] [Abstract][Full Text] [Related]
12. Iron protein succinylate in the treatment of iron deficiency: controlled, double-blind, multicenter clinical trial on over 1,000 patients.
Liguori L
Int J Clin Pharmacol Ther Toxicol; 1993 Mar; 31(3):103-23. PubMed ID: 8468108
[TBL] [Abstract][Full Text] [Related]
13. Reproductive safety studies with genistein in rats.
McClain RM; Wolz E; Davidovich A; Edwards J; Bausch J
Food Chem Toxicol; 2007 Aug; 45(8):1319-32. PubMed ID: 17433519
[TBL] [Abstract][Full Text] [Related]
14. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
15. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
Chan P
Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of efficacy and tolerability data on iron proteinsuccinylate in patients with iron deficiency anemia of different severity.
Köpcke W; Sauerland MC
Arzneimittelforschung; 1995 Nov; 45(11):1211-6. PubMed ID: 8929242
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of p-Nitrobenzoic Acid (CAS No. 62-23-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 442():1-306. PubMed ID: 12595921
[TBL] [Abstract][Full Text] [Related]
18. Controlled, double-blind, multicenter clinical trial of iron protein succinylate in the treatment of iron deficiency in children.
Careddu P; Scotti A
Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):157-69. PubMed ID: 8500917
[TBL] [Abstract][Full Text] [Related]
19. NTP technical report on the toxicity studies of a Chemical Mixture of 25 Groundwater Contaminants Administered in Drinking Water to F344/N Rats and B6C3F(1) Mice.
Yang R
Toxic Rep Ser; 1993 Aug; 35():1-I12. PubMed ID: 12209189
[TBL] [Abstract][Full Text] [Related]
20. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
